Procter & Gamble Co vs Progressive Corp — how do they compare? Procter & Gamble Co trades at $143.48 (market cap $338.13B), while Progressive Corp trades at $216.3 (market cap $124.88B). The key difference: Procter & Gamble Co is far larger — about 2.7× Progressive Corp's market cap, and Procter & Gamble Co pays the higher dividend (2.99%). Which is the better fit depends on your goals.
| PG | PGR | |
|---|---|---|
Market Cap | $338.13B | $124.88B |
Volume | 6,423,436 | — |
Sector | Consumer Staples | Financials |
52-Week High | $167.18 | $248.80 |
52-Week Low | $138.10 | $190.40 |
Enterprise Value | $363.97B | $133.09B |
Dividend Yield | 2.99% | 0.19% |
Signals from Pluang's Aura AI — not financial advice
Procter & Gamble (PG) trades at $145.59, down 0.57% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $1.89. Fundamentals show robust profitability, including a net income margin of 18.44% and ROE of 30.13%, though valuation ratios like P/E of 21.99 and P/S of 4.05 are at premiums to peers. Recent news highlights PG's dividend reliability and supply chain enhancements.
PG offers stability with consistent dividend growth and solid cash flows, but premium valuation and soft demand outlook pose near-term risks. Analyst consensus is bullish with a $161.20 price target, though technical weakness suggests potential consolidation. Key risks include economic sensitivity and competitive pressures, while institutional activity shows mixed positioning.
Progressive (PGR) trades at $214.90, down 1.85% on the day, with a bearish technical signal and neutral oscillators. The stock shows strong fundamentals with a P/E of 10.78, net income margin of 12.85%, and consistent revenue growth from $49.6B in 2022 to $87.6B in 2025. Recent earnings beat expectations in Q2 2026, but Q1 2026 missed. News highlights competition in auto insurance and institutional buying, while July 2026 earnings declined year-over-year due to expenses.
The outlook is mixed: valuation appears attractive with growth potential, but technical weakness and competitive pressures pose risks. Analyst consensus is a buy with a $231.18 price target, though hold ratings dominate at 52.38%. Key risks include expense management and market volatility, while institutional accumulation supports sentiment.
Trailing returns across standard periods
Latest headlines on both assets
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →Progressive underwrites private and commercial auto insurance and specialty lines
Read more on PGR →